世界のグアイフェネシン(API)市場:成長動向・競争分析2020-2026

【英語タイトル】Global Guaifenesin (API) Industry Research Report, Growth Trends and Competitive Analysis 2020-2026

QYResearchが出版した調査資料(QYR20AP00917)・商品コード:QYR20AP00917
・発行会社(調査会社):QYResearch
・発行日:2020年3月20日
・ページ数:119
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥656,600見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥984,900見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,313,200見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当リサーチレポートでは、グアイフェネシン(API)の世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、グアイフェネシン(API)のグローバル市場動向、メーカー別競争状況、種類別市場規模(98%-99%、>99%)、用途別市場規模(医薬品、その他)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・グアイフェネシン(API)の種類別市場2015-2026:98%-99%、>99%
・グアイフェネシン(API)の用途別市場2015-2026:医薬品、その他
・グアイフェネシン(API)の北米市場分析
・グアイフェネシン(API)のアジア市場分析
・グアイフェネシン(API)の中南米市場分析
・グアイフェネシン(API)の中東・アフリカ市場分析
・関連企業情報:Granules、Synthokem Labs、Haizhou Pharma、Yuan Cheng Group、Stellar Chemical、Biesterfeld、Seven Star Pharma、Camlin Fine Science、Gennex Lab、Iwaki Seiyaku、Pan Drugs、Delta Synthetic、Smart Pharm
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.The global average price of Guaifenesin (API) is in the decreasing trend, from 8.62 USD/Kg in 2012 to 7.61 USD/Kg in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.
In 2019, the global Guaifenesin (API) market size was US$ 56 million and is forecast to US$ 58 million in 2026, growing at a CAGR of 0.5% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Guaifenesin (API).
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Guaifenesin (API) market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Guaifenesin (API) market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Guaifenesin (API) market. Readers of the report can become informed about current and future trends of the global Guaifenesin (API) market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Guaifenesin (API) markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Guaifenesin (API) market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Guaifenesin (API) market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Guaifenesin (API) market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Guaifenesin (API) market is segmented into
98%-99%
>99%

Market Segment by Application, the Guaifenesin (API) market is segmented into
Pharmaceuticals
Others

This report includes the following manufacturers; we can also add the other companies as you want.
Granules
Synthokem Labs
Haizhou Pharma
Yuan Cheng Group
Stellar Chemical
Biesterfeld
Seven Star Pharma
Camlin Fine Science
Gennex Lab
Iwaki Seiyaku
Pan Drugs
Delta Synthetic
Smart Pharm

The study objectives are:
To analyze and research the global Guaifenesin (API) status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Guaifenesin (API) manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Guaifenesin (API) are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Guaifenesin (API) Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Guaifenesin (API) Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 98%-99%
1.3.3 >99%
1.4 Market Segment by Application
1.4.1 Global Guaifenesin (API) Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Pharmaceuticals
1.4.3 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Guaifenesin (API) Revenue (2015-2026)
2.1.1 Global Guaifenesin (API) Revenue (2015-2026)
2.1.2 Global Guaifenesin (API) Sales (2015-2026)
2.2 Guaifenesin (API) Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Guaifenesin (API) Sales by Regions (2015-2020)
2.2.2 Global Guaifenesin (API) Revenue by Regions (2015-2020)
2.3 Global Top Guaifenesin (API) Regions (Countries) Ranking by Market Size
2.4 Guaifenesin (API) Industry Trends
2.4.1 Guaifenesin (API) Market Top Trends
2.4.2 Market Drivers
2.4.3 Guaifenesin (API) Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Guaifenesin (API) Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Guaifenesin (API) Manufacturers by Sales (2015-2020)
3.1.1 Global Guaifenesin (API) Sales by Manufacturers (2015-2020)
3.1.2 Global Guaifenesin (API) Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Guaifenesin (API) Sales in 2019
3.2 Global Top Manufacturers Guaifenesin (API) by Revenue
3.2.1 Global Guaifenesin (API) Revenue by Manufacturers (2015-2020)
3.2.2 Global Guaifenesin (API) Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Guaifenesin (API) Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Guaifenesin (API) as of 2019)
3.4 Global Guaifenesin (API) Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Guaifenesin (API) Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Guaifenesin (API) Market
3.7 Key Manufacturers Guaifenesin (API) Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Guaifenesin (API) Historic Market Review by Type (2015-2020)
4.1.2 Global Guaifenesin (API) Sales Market Share by Type (2015-2020)
4.1.3 Global Guaifenesin (API) Revenue Market Share by Type (2015-2020)
4.1.4 Guaifenesin (API) Price by Type (2015-2020)
4.1 Global Guaifenesin (API) Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Guaifenesin (API) Sales Forecast by Type (2021-2026)
4.2.3 Global Guaifenesin (API) Revenue Forecast by Type (2021-2026)
4.2.4 Guaifenesin (API) Price Forecast by Type (2021-2026)

5 Global Guaifenesin (API) Market Size by Application
5.1 Global Guaifenesin (API) Historic Market Review by Application (2015-2020)
5.1.2 Global Guaifenesin (API) Sales Market Share by Application (2015-2020)
5.1.3 Global Guaifenesin (API) Revenue Market Share by Application (2015-2020)
5.1.4 Guaifenesin (API) Price by Application (2015-2020)
5.2 Global Guaifenesin (API) Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Guaifenesin (API) Sales Forecast by Application (2021-2026)
5.2.3 Global Guaifenesin (API) Revenue Forecast by Application (2021-2026)
5.2.4 Guaifenesin (API) Price Forecast by Application (2021-2026)

6 North America
6.1 North America Guaifenesin (API) Breakdown Data by Company
6.2 North America Guaifenesin (API) Breakdown Data by Type
6.3 North America Guaifenesin (API) Breakdown Data by Application
6.4 North America Guaifenesin (API) Breakdown Data by Countries
6.4.1 North America Guaifenesin (API) Sales by Countries
6.4.2 North America Guaifenesin (API) Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Guaifenesin (API) Breakdown Data by Company
7.2 Europe Guaifenesin (API) Breakdown Data by Type
7.3 Europe Guaifenesin (API) Breakdown Data by Application
7.4 Europe Guaifenesin (API) Breakdown Data by Countries
7.4.1 Europe Guaifenesin (API) Sales by Countries
7.4.2 Europe Guaifenesin (API) Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Guaifenesin (API) Breakdown Data by Company
8.2 Asia Pacific Guaifenesin (API) Breakdown Data by Type
8.3 Asia Pacific Guaifenesin (API) Breakdown Data by Application
8.4 Asia Pacific Guaifenesin (API) Breakdown Data by Regions
8.4.1 Asia Pacific Guaifenesin (API) Sales by Regions
8.4.2 Asia Pacific Guaifenesin (API) Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Guaifenesin (API) Breakdown Data by Company
9.2 Latin America Guaifenesin (API) Breakdown Data by Type
9.3 Latin America Guaifenesin (API) Breakdown Data by Application
9.4 Latin America Guaifenesin (API) Breakdown Data by Countries
9.4.1 Latin America Guaifenesin (API) Sales by Countries
9.4.2 Latin America Guaifenesin (API) Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Guaifenesin (API) Breakdown Data by Type
10.2 Middle East and Africa Guaifenesin (API) Breakdown Data by Application
10.3 Middle East and Africa Guaifenesin (API) Breakdown Data by Countries
10.3.1 Middle East and Africa Guaifenesin (API) Sales by Countries
10.3.2 Middle East and Africa Guaifenesin (API) Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Granules
11.1.1 Granules Corporation Information
11.1.2 Granules Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Granules Guaifenesin (API) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Granules Guaifenesin (API) Products and Services
11.1.5 Granules SWOT Analysis
11.1.6 Granules Recent Developments
11.2 Synthokem Labs
11.2.1 Synthokem Labs Corporation Information
11.2.2 Synthokem Labs Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Synthokem Labs Guaifenesin (API) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Synthokem Labs Guaifenesin (API) Products and Services
11.2.5 Synthokem Labs SWOT Analysis
11.2.6 Synthokem Labs Recent Developments
11.3 Haizhou Pharma
11.3.1 Haizhou Pharma Corporation Information
11.3.2 Haizhou Pharma Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Haizhou Pharma Guaifenesin (API) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Haizhou Pharma Guaifenesin (API) Products and Services
11.3.5 Haizhou Pharma SWOT Analysis
11.3.6 Haizhou Pharma Recent Developments
11.4 Yuan Cheng Group
11.4.1 Yuan Cheng Group Corporation Information
11.4.2 Yuan Cheng Group Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Yuan Cheng Group Guaifenesin (API) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Yuan Cheng Group Guaifenesin (API) Products and Services
11.4.5 Yuan Cheng Group SWOT Analysis
11.4.6 Yuan Cheng Group Recent Developments
11.5 Stellar Chemical
11.5.1 Stellar Chemical Corporation Information
11.5.2 Stellar Chemical Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Stellar Chemical Guaifenesin (API) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Stellar Chemical Guaifenesin (API) Products and Services
11.5.5 Stellar Chemical SWOT Analysis
11.5.6 Stellar Chemical Recent Developments
11.6 Biesterfeld
11.6.1 Biesterfeld Corporation Information
11.6.2 Biesterfeld Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Biesterfeld Guaifenesin (API) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Biesterfeld Guaifenesin (API) Products and Services
11.6.5 Biesterfeld SWOT Analysis
11.6.6 Biesterfeld Recent Developments
11.7 Seven Star Pharma
11.7.1 Seven Star Pharma Corporation Information
11.7.2 Seven Star Pharma Business Overview and Total Revenue (2019 VS 2018)
11.7.3 Seven Star Pharma Guaifenesin (API) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 Seven Star Pharma Guaifenesin (API) Products and Services
11.7.5 Seven Star Pharma SWOT Analysis
11.7.6 Seven Star Pharma Recent Developments
11.8 Camlin Fine Science
11.8.1 Camlin Fine Science Corporation Information
11.8.2 Camlin Fine Science Business Overview and Total Revenue (2019 VS 2018)
11.8.3 Camlin Fine Science Guaifenesin (API) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.8.4 Camlin Fine Science Guaifenesin (API) Products and Services
11.8.5 Camlin Fine Science SWOT Analysis
11.8.6 Camlin Fine Science Recent Developments
11.9 Gennex Lab
11.9.1 Gennex Lab Corporation Information
11.9.2 Gennex Lab Business Overview and Total Revenue (2019 VS 2018)
11.9.3 Gennex Lab Guaifenesin (API) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.9.4 Gennex Lab Guaifenesin (API) Products and Services
11.9.5 Gennex Lab SWOT Analysis
11.9.6 Gennex Lab Recent Developments
11.10 Iwaki Seiyaku
11.10.1 Iwaki Seiyaku Corporation Information
11.10.2 Iwaki Seiyaku Business Overview and Total Revenue (2019 VS 2018)
11.10.3 Iwaki Seiyaku Guaifenesin (API) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.10.4 Iwaki Seiyaku Guaifenesin (API) Products and Services
11.10.5 Iwaki Seiyaku SWOT Analysis
11.10.6 Iwaki Seiyaku Recent Developments
11.11 Pan Drugs
11.11.1 Pan Drugs Corporation Information
11.11.2 Pan Drugs Business Overview and Total Revenue (2019 VS 2018)
11.11.3 Pan Drugs Guaifenesin (API) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.11.4 Pan Drugs Guaifenesin (API) Products and Services
11.11.5 Pan Drugs SWOT Analysis
11.11.6 Pan Drugs Recent Developments
11.12 Delta Synthetic
11.12.1 Delta Synthetic Corporation Information
11.12.2 Delta Synthetic Business Overview and Total Revenue (2019 VS 2018)
11.12.3 Delta Synthetic Guaifenesin (API) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.12.4 Delta Synthetic Guaifenesin (API) Products and Services
11.12.5 Delta Synthetic SWOT Analysis
11.12.6 Delta Synthetic Recent Developments
11.13 Smart Pharm
11.13.1 Smart Pharm Corporation Information
11.13.2 Smart Pharm Business Overview and Total Revenue (2019 VS 2018)
11.13.3 Smart Pharm Guaifenesin (API) Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.13.4 Smart Pharm Guaifenesin (API) Products and Services
11.13.5 Smart Pharm SWOT Analysis
11.13.6 Smart Pharm Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Guaifenesin (API) Sales Channels
12.2.2 Guaifenesin (API) Distributors
12.3 Guaifenesin (API) Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Guaifenesin (API) Sales Forecast (2021-2026)
13.1.1 Global Guaifenesin (API) Sales Forecast by Regions (2021-2026)
13.1.2 Global Guaifenesin (API) Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Guaifenesin (API) Sales Forecast (2021-2026)
13.2.2 North America Guaifenesin (API) Revenue Forecast (2021-2026)
13.2.3 North America Guaifenesin (API) Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Guaifenesin (API) Sales Forecast (2021-2026)
13.3.2 Europe Guaifenesin (API) Revenue Forecast (2021-2026)
13.3.3 Europe Guaifenesin (API) Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Guaifenesin (API) Sales Forecast (2021-2026)
13.4.2 Asia Pacific Guaifenesin (API) Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Guaifenesin (API) Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Guaifenesin (API) Sales Forecast (2021-2026)
13.5.2 Latin America Guaifenesin (API) Revenue Forecast (2021-2026)
13.5.3 Latin America Guaifenesin (API) Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Guaifenesin (API) Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Guaifenesin (API) Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Guaifenesin (API) Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Guaifenesin (API) Key Market Segments
Table 2. Ranking of Global Top Guaifenesin (API) Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Guaifenesin (API) Market Size Growth Rate by Type 2021-2026 (MT) & (Million US$)
Table 4. Major Manufacturers of 98%-99%
Table 5. Major Manufacturers of >99%
Table 6. Global Guaifenesin (API) Market Share by Application 2019-2025 (MT)
Table 7. Global Guaifenesin (API) Market Size by Regions 2015-2020 (MT) & (Million US$)
Table 8. Global Guaifenesin (API) Sales by Regions 2015-2020 (MT)
Table 9. Global Guaifenesin (API) Sales Market Share by Regions 2015-2020
Table 10. Global Guaifenesin (API) Revenue by Regions 2015-2020 (Million US$)
Table 11. Global Guaifenesin (API) Revenue Market Share by Regions 2015-2020
Table 12. Top Guaifenesin (API) Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 13. Market Top Trends
Table 14. Guaifenesin (API) Key Drivers: Impact Analysis (2021-2026)
Table 15. Guaifenesin (API) Key Challenges
Table 16. Main Points Interviewed from Key Guaifenesin (API) Players: Views for Future
Table 17. Global Guaifenesin (API) Sales by Manufacturers (2015-2020) (MT)
Table 18. Global Guaifenesin (API) Sales Share by Manufacturers (2015-2020)
Table 19. Guaifenesin (API) Revenue by Manufacturers (2015-2020) (Million US$)
Table 20. Guaifenesin (API) Revenue Share by Manufacturers (2015-2020)
Table 21. Global Guaifenesin (API) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Guaifenesin (API) as of 2019)
Table 23. Key Manufacturers Guaifenesin (API) Average Selling Price (ASP) (2015-2020) (USD/Kg)
Table 24. Key Manufacturers Guaifenesin (API) Plants/Factories Distribution
Table 25. Key Manufacturers Guaifenesin (API) Area Served
Table 26. Date of Key Manufacturers Enter into Guaifenesin (API) Market
Table 27. Key Manufacturers Guaifenesin (API) Product Type
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global 98%-99% Sales and Revenue (2015-2020) (MT) & (Million US$)
Table 30. Global >99% Sales and Revenue (2015-2020) (MT) & (Million US$)
Table 31. Global Guaifenesin (API) Sales (MT) by Type (2015-2020)
Table 32. Global Guaifenesin (API) Sales Share by Type (2015-2020)
Table 33. Global Guaifenesin (API) Revenue (US$ Million) Market Share by Type (2015-2020)
Table 34. Global Guaifenesin (API) Price (MT) by Type (2015-2020)
Table 35. Global Guaifenesin (API) Sales (MT) by Type (2021-2026)
Table 36. Global Guaifenesin (API) Sales Share by Type (2021-2026)
Table 37. Global Guaifenesin (API) Revenue (US$ Million) Market Share by Type (2021-2026)
Table 38. Global Guaifenesin (API) Revenue Share by Type (2021-2026)
Table 39. Global Guaifenesin (API) Price (MT) by Type (2021-2026)
Table 40. Global Guaifenesin (API) Sales (MT) by Application (2015-2020)
Table 41. Global Guaifenesin (API) Sales Share by Application (2015-2020)
Table 42. Global Guaifenesin (API) Revenue (US$ Million) Market Share by Application (2015-2020)
Table 43. Global Guaifenesin (API) Price by Application 2015-2020 (USD/Kg)
Table 44. Global Guaifenesin (API) Sales by Application (2015-2020) (MT)
Table 45. Global Guaifenesin (API) Sales Share by Application (2015-2020)
Table 46. Global Guaifenesin (API) Revenue (US$ Million) Market Share by Application (2021-2026)
Table 47. Global Guaifenesin (API) Revenue Share by Application (2021-2026)
Table 48. Global Guaifenesin (API) Price (MT) by Application (2021-2026)
Table 49. North America Guaifenesin (API) Sales by Company (2015-2020) (MT)
Table 50. North America Guaifenesin (API) Sales Market Share by Company (2015-2020)
Table 51. North America Guaifenesin (API) Sales by Type (2015-2020) (MT)
Table 52. North America Guaifenesin (API) Sales Market Share by Type (2015-2020)
Table 53. North America Guaifenesin (API) Sales by Application (2015-2020) (MT)
Table 54. North America Guaifenesin (API) Sales Market Share by Application (2015-2020)
Table 55. North America Guaifenesin (API) Sales by Countries (2015-2020) (MT)
Table 56. North America Guaifenesin (API) Sales Market Share by Countries (2015-2020)
Table 57. North America Guaifenesin (API) Revenue by Countries (2015-2020) (Million US$)
Table 58. North America Guaifenesin (API) Revenue Market Share by Countries (2015-2020)
Table 59. Europe Guaifenesin (API) Sales by Company (2015-2020) (MT)
Table 60. Europe Guaifenesin (API) Sales Market Share by Company (2015-2020)
Table 61. Europe Guaifenesin (API) Sales by Type (2015-2020) (MT)
Table 62. Europe Guaifenesin (API) Sales Market Share by Type (2015-2020)
Table 63. Europe Guaifenesin (API) Sales by Application (2015-2020) (MT)
Table 64. Europe Guaifenesin (API) Sales Market Share by Application (2015-2020)
Table 65. Europe Guaifenesin (API) Sales by Countries (2015-2020) (MT)
Table 66. Europe Guaifenesin (API) Sales Market Share by Countries (2015-2020)
Table 67. Europe Guaifenesin (API) Revenue by Countries (2015-2020) (Million US$)
Table 68. Europe Guaifenesin (API) Revenue Market Share by Countries (2015-2020)
Table 69. Asia Pacific Guaifenesin (API) Sales by Regions (2015-2020) (MT)
Table 70. Asia Pacific Guaifenesin (API) Sales Market Share by Regions (2015-2020)
Table 71. Asia Pacific Guaifenesin (API) Sales by Type (2015-2020) (MT)
Table 72. Asia Pacific Guaifenesin (API) Sales Market Share by Type (2015-2020)
Table 73. Asia Pacific Guaifenesin (API) Sales by Application (2015-2020) (MT)
Table 74. Asia Pacific Guaifenesin (API) Sales Market Share by Application (2015-2020)
Table 75. Asia Pacific Guaifenesin (API) Sales by Countries (2015-2020) (MT)
Table 76. Asia Pacific Guaifenesin (API) Sales Market Share by Regions (2015-2020)
Table 77. Asia Pacific Guaifenesin (API) Revenue by Regions (2015-2020) (Million US$)
Table 78. Asia Pacific Guaifenesin (API) Revenue Market Share by Regions (2015-2020)
Table 79. Latin America Guaifenesin (API) Sales by Company (2015-2020) (MT)
Table 80. Latin America Guaifenesin (API) Sales Market Share by Company (2015-2020)
Table 81. Latin America Guaifenesin (API) Sales by Type (2015-2020) (MT)
Table 82. Latin America Guaifenesin (API) Sales Market Share by Type (2015-2020)
Table 83. Latin America Guaifenesin (API) Sales by Application (2015-2020) (MT)
Table 84. Latin America Guaifenesin (API) Sales Market Share by Application (2015-2020)
Table 85. Latin America Guaifenesin (API) Sales by Countries (2015-2020) (MT)
Table 86. Latin America Guaifenesin (API) Sales Market Share by Countries (2015-2020)
Table 87. Latin America Guaifenesin (API) Revenue by Countries (2015-2020) (Million US$)
Table 88. Latin America Guaifenesin (API) Revenue Market Share by Countries (2015-2020)
Table 89. Middle East and Africa Guaifenesin (API) Sales by Type (2015-2020) (MT)
Table 90. Middle East and Africa Guaifenesin (API) Sales Market Share by Type (2015-2020)
Table 91. Middle East and Africa Guaifenesin (API) Sales by Application (2015-2020) (MT)
Table 92. Middle East and Africa Guaifenesin (API) Sales Market Share by Application (2015-2020)
Table 93. Middle East and Africa Guaifenesin (API) Sales by Countries (2015-2020) (MT)
Table 94. Middle East and Africa Guaifenesin (API) Sales Market Share by Countries (2015-2020)
Table 95. Middle East and Africa Guaifenesin (API) Revenue by Countries (2015-2020) (Million US$)
Table 96. Middle East and Africa Guaifenesin (API) Revenue Market Share by Countries (2015-2020)
Table 97. Granules Company Details
Table 98. Granules Description and Business Overview
Table 99. Granules Guaifenesin (API) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 100. Granules Guaifenesin (API) Sales Growth Rate (2015-2020)
Table 101. Granules Guaifenesin (API) Sales Market Share in Global Market
Table 102. Granules Recent Development
Table 103. Synthokem Labs Company Details
Table 104. Synthokem Labs Description and Business Overview
Table 105. Synthokem Labs Guaifenesin (API) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 106. Synthokem Labs Guaifenesin (API) Sales Growth Rate (2015-2020)
Table 107. Synthokem Labs Guaifenesin (API) Sales Market Share in Global Market
Table 108. Synthokem Labs Recent Development
Table 109. Haizhou Pharma Company Details
Table 110. Haizhou Pharma Description and Business Overview
Table 111. Haizhou Pharma Guaifenesin (API) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 112. Haizhou Pharma Guaifenesin (API) Sales Growth Rate (2015-2020)
Table 113. Haizhou Pharma Guaifenesin (API) Sales Market Share in Global Market
Table 114. Haizhou Pharma Recent Development
Table 115. Yuan Cheng Group Company Details
Table 116. Yuan Cheng Group Description and Business Overview
Table 117. Yuan Cheng Group Guaifenesin (API) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 118. Yuan Cheng Group Guaifenesin (API) Sales Growth Rate (2015-2020)
Table 119. Yuan Cheng Group Guaifenesin (API) Sales Market Share in Global Market
Table 120. Yuan Cheng Group Recent Development
Table 121. Stellar Chemical Company Details
Table 122. Stellar Chemical Description and Business Overview
Table 123. Stellar Chemical Guaifenesin (API) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 124. Stellar Chemical Guaifenesin (API) Sales Growth Rate (2015-2020)
Table 125. Stellar Chemical Guaifenesin (API) Sales Market Share in Global Market
Table 126. Stellar Chemical Recent Development
Table 127. Biesterfeld Company Details
Table 128. Biesterfeld Description and Business Overview
Table 129. Biesterfeld Guaifenesin (API) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 130. Biesterfeld Guaifenesin (API) Sales Growth Rate (2015-2020)
Table 131. Biesterfeld Guaifenesin (API) Sales Market Share in Global Market
Table 132. Biesterfeld Recent Development
Table 133. Seven Star Pharma Company Details
Table 134. Seven Star Pharma Description and Business Overview
Table 135. Seven Star Pharma Guaifenesin (API) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 136. Seven Star Pharma Guaifenesin (API) Sales Growth Rate (2015-2020)
Table 137. Seven Star Pharma Guaifenesin (API) Sales Market Share in Global Market
Table 138. Seven Star Pharma Recent Development
Table 139. Camlin Fine Science Company Details
Table 140. Camlin Fine Science Description and Business Overview
Table 141. Camlin Fine Science Guaifenesin (API) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 142. Camlin Fine Science Guaifenesin (API) Sales Growth Rate (2015-2020)
Table 143. Camlin Fine Science Guaifenesin (API) Sales Market Share in Global Market
Table 144. Camlin Fine Science Recent Development
Table 145. Gennex Lab Company Details
Table 146. Gennex Lab Description and Business Overview
Table 147. Gennex Lab Guaifenesin (API) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 148. Gennex Lab Guaifenesin (API) Sales Growth Rate (2015-2020)
Table 149. Gennex Lab Guaifenesin (API) Sales Market Share in Global Market
Table 150. Gennex Lab Recent Development
Table 151. Iwaki Seiyaku Company Details
Table 152. Iwaki Seiyaku Description and Business Overview
Table 153. Iwaki Seiyaku Guaifenesin (API) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 154. Iwaki Seiyaku Guaifenesin (API) Sales Growth Rate (2015-2020)
Table 155. Iwaki Seiyaku Guaifenesin (API) Sales Market Share in Global Market
Table 156. Iwaki Seiyaku Recent Development
Table 157. Pan Drugs Company Details
Table 158. Pan Drugs Description and Business Overview
Table 159. Pan Drugs Guaifenesin (API) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 160. Pan Drugs Guaifenesin (API) Sales Growth Rate (2015-2020)
Table 161. Pan Drugs Guaifenesin (API) Sales Market Share in Global Market
Table 162. Pan Drugs Recent Development
Table 163. Delta Synthetic Company Details
Table 164. Delta Synthetic Description and Business Overview
Table 165. Delta Synthetic Guaifenesin (API) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 166. Delta Synthetic Guaifenesin (API) Sales Growth Rate (2015-2020)
Table 167. Delta Synthetic Guaifenesin (API) Sales Market Share in Global Market
Table 168. Delta Synthetic Recent Development
Table 169. Smart Pharm Company Details
Table 170. Smart Pharm Description and Business Overview
Table 171. Smart Pharm Guaifenesin (API) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 172. Smart Pharm Guaifenesin (API) Sales Growth Rate (2015-2020)
Table 173. Smart Pharm Guaifenesin (API) Sales Market Share in Global Market
Table 174. Smart Pharm Recent Development
Table 175. Guaifenesin (API) Distributors List
Table 176. Guaifenesin (API) Customers List
Table 177. Global Guaifenesin (API) Sales Forecast 2021-2026 (MT) & (Million US$)
Table 178. Global Guaifenesin (API) Sales Forecast by Type 2021-2026 (MT)
Table 179. Global Guaifenesin (API) Sales Forecast by Application 2021-2026 (MT)
Table 180. Global Guaifenesin (API) Sales Forecast by Regions 2021-2026 (MT)
Table 181. Global Guaifenesin (API) Revenue Forecast by Regions 2021-2026 (Million US$)
Table 182. North America Guaifenesin (API) Sales Forecast by Countries 2021-2026 (MT)
Table 183. North America Guaifenesin (API) Revenue Forecast by Countries 2021-2026
Table 184. Europe Guaifenesin (API) Sales Forecast by Countries 2021-2026 (MT)
Table 185. Europe Guaifenesin (API) Revenue Market Share Forecast by Countries 2021-2026
Table 186. Asia Pacific Guaifenesin (API) Sales Forecast by Regions 2021-2026 (MT)
Table 187. Asia Pacific Guaifenesin (API) Revenue Forecast by Regions 2021-2026 (Million US$)
Table 188. Latin America Guaifenesin (API) Sales Forecast by Countries 2021-2026 (MT)
Table 189. Latin America Guaifenesin (API) Revenue Forecast by Countries 2021-2026 (Million US$)
Table 190. Middle East and Africa Guaifenesin (API) Sales Forecast by Regions 2021-2026 (MT)
Table 191. Middle East and Africa Guaifenesin (API) Revenue Forecast by Regions 2021-2026 (Million US$)
Table 192. Research Programs/Design for This Report
Table 193. Key Data Information from Secondary Sources
Table 194. Key Data Information from Primary Sources
List of Figures
Figure 1. Guaifenesin (API) Product Picture
Figure 2. Global Guaifenesin (API) Sales Market Shar by Type 2015-2026
Figure 3. 98%-99% Figures
Figure 4. >99% Figures
Figure 5. Global Guaifenesin (API) Sales Market Share by Application in 2019 & 2026
Figure 6. Pharmaceuticals Use Case
Figure 7. Others Use Case
Figure 8. Guaifenesin (API) Report Years Considered
Figure 9. Global Guaifenesin (API) Market Size 2015-2026 (Million US$)
Figure 10. Global Guaifenesin (API) Sales 2015-2020 (MT)
Figure 11. Global Guaifenesin (API) Market Size Market Share by Regions 2015-2020
Figure 12. Global Guaifenesin (API) Sales Market Share by Regions in 2019
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Guaifenesin (API) Sales Share by Manufacturers in 2019
Figure 15. The 5 and 10 Largest Manufacturers in the World: Market Share by Guaifenesin (API) Sales in 2019
Figure 16. Guaifenesin (API) Value Share by Manufacturers in 2019
Figure 17. Guaifenesin (API) Revenue Share by Manufacturers In 2019
Figure 18. Guaifenesin (API) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Guaifenesin (API) Revenue Share by Type (2015-2020)
Figure 20. Global Guaifenesin (API) Revenue Growth Rate by Type in 2015 & 2019
Figure 21. Global Guaifenesin (API) Market Share by Price Range (2015-2020)
Figure 22. Global Guaifenesin (API) Revenue Share by Application (2015-2020)
Figure 23. Global Guaifenesin (API) Revenue Growth Rate by Application in 2015 & 2019
Figure 24. North America Guaifenesin (API) Revenue Growth Rate 2015-2020 (Million US$)
Figure 25. U.S. Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 26. Canada Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 27. Europe Guaifenesin (API) Revenue Growth Rate 2015-2020 (Million US$)
Figure 28. Germany Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 29. France Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 30. U.K. Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 31. Italy Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 32. Russia Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 33. Asia Pacific Guaifenesin (API) Revenue Growth Rate 2015-2020 (Million US$)
Figure 34. China Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 35. Japan Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 36. South Korea Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 37. India Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 38. Australia Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 39. Taiwan Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 40. Indonesia Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 41. Thailand Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 42. Malaysia Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 43. Philippines Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 44. Vietnam Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 45. Latin America Guaifenesin (API) Revenue Growth Rate 2015-2020 (Million US$)
Figure 46. Mexico Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 47. Brazil Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 48. Argentina Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 49. Middle East and Africa Guaifenesin (API) Revenue Growth Rate 2015-2020 (Million US$)
Figure 50. Turkey Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 51. Saudi Arabia Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 52. U.A.E Guaifenesin (API) Sales Growth Rate (2015-2020) (MT)
Figure 53. Granules Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Synthokem Labs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Haizhou Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Yuan Cheng Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Stellar Chemical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Biesterfeld Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Seven Star Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Camlin Fine Science Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Gennex Lab Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Iwaki Seiyaku Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Pan Drugs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Delta Synthetic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Smart Pharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Guaifenesin (API) Value Chain
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
Figure 69. North America Guaifenesin (API) Sales Growth Rate Forecast (2021-2026) (MT)
Figure 70. North America Guaifenesin (API) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 71. Europe Guaifenesin (API) Sales Growth Rate Forecast (2021-2026) (MT)
Figure 72. Europe Guaifenesin (API) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 73. Asia Pacific Guaifenesin (API) Sales Growth Rate Forecast (2021-2026) (MT)
Figure 74. Asia Pacific Guaifenesin (API) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 75. Latin America Guaifenesin (API) Sales Growth Rate Forecast (2021-2026) (MT)
Figure 76. Latin America Guaifenesin (API) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 77. Middle East and Africa Guaifenesin (API) Sales Growth Rate Forecast (2021-2026) (MT)
Figure 78. Middle East and Africa Guaifenesin (API) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed


【掲載企業】

Granules、Synthokem Labs、Haizhou Pharma、Yuan Cheng Group、Stellar Chemical、Biesterfeld、Seven Star Pharma、Camlin Fine Science、Gennex Lab、Iwaki Seiyaku、Pan Drugs、Delta Synthetic、Smart Pharm

★調査レポート[世界のグアイフェネシン(API)市場:成長動向・競争分析2020-2026] (コード:QYR20AP00917)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のグアイフェネシン(API)市場:成長動向・競争分析2020-2026]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆